What does Dr. Ph. Catry do?

Dr. Ph. Catry is a specialist medical practice in Aartselaar. Private Limited, started on 21 June 2012, 1 establishment.

What is the address of Dr. Ph. Catry?

The registered office of Dr. Ph. Catry is located at Drie Bunder 19, 2630 Aartselaar.

Is Dr. Ph. Catry still active?

Yes. According to the CBE (18 September 2026) Dr. Ph. Catry is active, legal situation “Normale toestand”, started on 21 June 2012.

Is Dr. Ph. Catry registered on Peppol?

Yes, Dr. Ph. Catry is registered on the Peppol network with ID 0208:0846860676.

What is the enterprise number of Dr. Ph. Catry?

The enterprise number of Dr. Ph. Catry is BE0846860676.

When was Dr. Ph. Catry founded?

Dr. Ph. Catry was founded on 21 June 2012.

Who are the directors of Dr. Ph. Catry?

According to the 2025 annual accounts, the directors of Dr. Ph. Catry are: Philippe Catry.

Is Dr. Ph. Catry a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 June 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Ph. Catry make in 2025?

Dr. Ph. Catry posted a profit after taxes of € 195,843 in financial year 2025.

What is the revenue of Dr. Ph. Catry?

As a small company, Dr. Ph. Catry is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 328,729.

Dr. Ph. Catry (Private Limited) - Aartselaar

Dossier Dr. Ph. Catry, printed on 18 September 2026 from databakkes.be/en/0846860676/dr-ph-catry. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 63 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Ph. Catry from Aartselaar, company number BE0846860676, closed financial year 2025 with a result of € 195,843 after tax. For that financial year Dr. Ph. Catry recorded a gross margin of € 328,729 and equity of € 1 million. Compared with financial year 2024, the result moved from € 321,422 to € 195,843. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 18, 2026.

What it is worth Growing

€ 1 million

▲ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 195,843

▼ 39% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 137,069

▲ 28% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 107,250 paid out

55 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 43,067

▼ 10% vs 2024

Of which on lease € 29,053.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 407,356

▼ 6% vs 2024

€ 61,689 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 8,364

▼ 40% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 68,404

▼ 5% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 227,431 Gross margin 2022: € 227,431 First fiscal year in the series	€ 354,540 Gross margin 2023: € 354,540 ▲ 56% vs 2022 (€ 227,431) Favourable step	€ 345,571 Gross margin 2024: € 345,571 ▼ 3% vs 2023 (€ 354,540) Unfavourable step	€ 328,729 Gross margin 2025: € 328,729 ▼ 5% vs 2024 (€ 345,571) Unfavourable step	▼ 5%
Profit after taxes	€ 105,675 Profit after taxes 2022: € 105,675 First fiscal year in the series	€ 199,298 Profit after taxes 2023: € 199,298 ▲ 89% vs 2022 (€ 105,675) Favourable step	€ 321,422 Profit after taxes 2024: € 321,422 ▲ 61% vs 2023 (€ 199,298) Favourable step	€ 195,843 Profit after taxes 2025: € 195,843 ▼ 39% vs 2024 (€ 321,422) Unfavourable step	▼ 39%
Equity	€ 785,968 Equity 2022: € 785,968 First fiscal year in the series	€ 758,706 Equity 2023: € 758,706 ▼ 3% vs 2022 (€ 785,968) Unfavourable step	€ 921,488 Equity 2024: € 921,488 ▲ 21% vs 2023 (€ 758,706) Favourable step	€ 1,010,082 Equity 2025: € 1,010,082 ▲ 10% vs 2024 (€ 921,488) Favourable step	▲ 10%
Total debts	€ 674,735 Total debts 2022: € 674,735 First fiscal year in the series	€ 710,272 Total debts 2023: € 710,272 ▲ 5% vs 2022 (€ 674,735) Unfavourable step	€ 676,835 Total debts 2024: € 676,835 ▼ 5% vs 2023 (€ 710,272) Favourable step	€ 597,120 Total debts 2025: € 597,120 ▼ 12% vs 2024 (€ 676,835) Favourable step	▼ 12%
Cash	€ 127,114 Cash 2022: € 127,114 First fiscal year in the series	€ 88,274 Cash 2023: € 88,274 ▼ 31% vs 2022 (€ 127,114) Unfavourable step	€ 107,210 Cash 2024: € 107,210 ▲ 21% vs 2023 (€ 88,274) Favourable step	€ 137,069 Cash 2025: € 137,069 ▲ 28% vs 2024 (€ 107,210) Favourable step	▲ 28%
Land & buildings	€ 714,491 Land & buildings 2022: € 714,491 First fiscal year in the series	€ 689,937 Land & buildings 2023: € 689,937 ▼ 3% vs 2022 (€ 714,491) Unchanged	€ 684,718 Land & buildings 2024: € 684,718 ▼ 1% vs 2023 (€ 689,937) Unchanged	€ 658,696 Land & buildings 2025: € 658,696 ▼ 4% vs 2024 (€ 684,718) Unchanged	▼ 4%
Retained profit	€ 773,568 Retained profit 2022: € 773,568 First fiscal year in the series	€ 746,306 Retained profit 2023: € 746,306 ▼ 4% vs 2022 (€ 773,568) Unfavourable step	€ 909,088 Retained profit 2024: € 909,088 ▲ 22% vs 2023 (€ 746,306) Favourable step	€ 997,682 Retained profit 2025: € 997,682 ▲ 10% vs 2024 (€ 909,088) Favourable step	▲ 10%
Dividend	€ 155,000 Dividend 2022: € 155,000 First fiscal year in the series	€ 226,560 Dividend 2023: € 226,560 ▲ 46% vs 2022 (€ 155,000) Unchanged	€ 158,640 Dividend 2024: € 158,640 ▼ 30% vs 2023 (€ 226,560) Unchanged	€ 107,250 Dividend 2025: € 107,250 ▼ 32% vs 2024 (€ 158,640) Unchanged	▼ 32%
Bank debt	€ 494,670 Bank debt 2022: € 494,670 First fiscal year in the series	€ 465,200 Bank debt 2023: € 465,200 ▼ 6% vs 2022 (€ 494,670) Favourable step	€ 434,909 Bank debt 2024: € 434,909 ▼ 7% vs 2023 (€ 465,200) Favourable step	€ 407,356 Bank debt 2025: € 407,356 ▼ 6% vs 2024 (€ 434,909) Favourable step	▼ 6%
Balance sheet total	€ 1,460,703 Balance sheet total 2022: € 1,460,703 First fiscal year in the series	€ 1,468,979 Balance sheet total 2023: € 1,468,979 ▲ 1% vs 2022 (€ 1,460,703) Unchanged	€ 1,598,324 Balance sheet total 2024: € 1,598,324 ▲ 9% vs 2023 (€ 1,468,979) Unchanged	€ 1,607,202 Balance sheet total 2025: € 1,607,202 ▲ 1% vs 2024 (€ 1,598,324) Unchanged	▲ 1%

Key figures of Dr. Ph. Catry, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Ph. Catry?

What happened at Dr. Ph. Catry in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 18, 2026 New annual accounts for financial year 2025: profit of € 195,843 (▼ 39% vs 2024). filed late Source: NBB ↗
Jun 21, 2012 New establishment in Aartselaar. KBO
Jun 21, 2012 Start of the company according to the CBE. KBO

In short

From € 105,675 profit in 2022 to € 195,843 profit in 2025.

Paid € 359,653 in corporate taxes since 2022.

Best year ever: 2024, with € 321,422 profit.

Paid out € 647,450 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Ph. Catry? We notify you, reason included.

Follow Dr. Ph. Catry

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Philippe Catry

Dr. Ph. Catry

Behind Dr. Ph. Catry is Philippe Catry.

See the full network in the app

Directors

According to the 2025 annual accounts

Philippe Catry

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Drie Bunder 19

2630 Aartselaar

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0846.860.676
VAT number: BE 0846.860.676
Registered office: Drie Bunder 19, 2630 Aartselaar
Names & denominations: Dr. Ph. Catry
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 June 2012
Peppol: Active · Active since 23 Sept 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗